PLK4 is overexpressed in lung carcinoma and is associated with unfavorable survival; high PLK4 expression correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer. Here, PLK4 is linked to non-small cell lung carcinoma.